Publications by authors named "Tetsuo Michihata"

Claim this Profile
E
Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis.
Hirokazu Honda, Kenji Tanaka, Tetsuo Michihata, Keigo Shibagaki, Toshitaka Yuza

Clin Kidney J· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Impacts of Intravenous Iron Administration and Iron-Containing Phosphate Binders on Serum Intact Fibroblast Growth Factor 23 Levels.
Hirokazu Honda, Kenji Tanaka, Tetsuo Michihata, Keigo Shibagaki, Toshitaka Yuza

Blood Purif· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients.
Hirokazu Honda, Tetsuo Michihata, Kanji Shishido, Keiko Takahashi, Go Takahashi

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.
Hirokazu Honda, Tsutomu Hirano, Masashi Ueda, Shiho Kojima, Shinichi Mashiba, Tetsuo Michihata

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease.
Hirokazu Honda, Tsutomu Hirano, Masashi Ueda, Shiho Kojima, Shinichi Mashiba, Tetsuo Michihata

J Atheroscler Thromb· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Long-Term Erythropoiesis-Stimulating Agents on Iron Metabolism in Patients on Hemodialysis.
Shoko Onuma, Hirokazu Honda, Yasuna Kobayashi, Toshinori Yamamoto, Tetsuo Michihata

Ther Apher Dial· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active vitamin D analogs, maxacalcitol and alfacalcidol, as maintenance therapy for mild secondary hyperparathyroidism in hemodialysis patients - a randomized study.
Hirokazu Honda, Fumihiko Koiwa, Hiroaki Ogata, Kanji Shishido, Takashi Sekiguchi, Tetsuo Michihata

Int J Clin Pharmacol Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
Hirokazu Honda, Nozomu Hosaka, Yumie Aoshima, Yuki Hirai, Tetsuo Michihata

Clin Exp Hypertens· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
Hirokazu Honda, Masashi Ueda, Shiho Kojima, Shinichi Mashiba, Tetsuo Michihata

Atherosclerosis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of inflow of endotoxin and its fragments in patients on maintenance hemodialysis.
Hiroki Suzuki, Hirokazu Honda, Noriyuki Kato, Tetsuo Michihata, Keiko Takahashi

Blood Purif· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis